Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
- PMID: 16870507
- DOI: 10.1016/j.coph.2006.04.005
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
Abstract
Staphylococcal infections not only remain an important cause of morbidity and mortality in both the community and the clinic, but the emergence of a global pandemic of community-associated methicillin-resistant Staphylococcus aureus, involving what purports to be a more virulent strain of this organism, has also led several in the infectious disease community to call for improved disease prevention strategies (in addition to novel therapeutics) in what could be thought of as the microbiological version of pre-emption. In this case, Staphylococcus aureus possesses "weapons of mass destruction" and appears to be using them effectively as part of anti-immunization insurgency.
Similar articles
-
MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection.Curr Opin Drug Discov Devel. 2004 Mar;7(2):223-7. Curr Opin Drug Discov Devel. 2004. PMID: 15603256 Review.
-
Staphylococcus aureus antigens and challenges in vaccine development.Expert Rev Vaccines. 2008 Aug;7(6):805-15. doi: 10.1586/14760584.7.6.805. Expert Rev Vaccines. 2008. PMID: 18665778 Review.
-
Immunotherapeutic strategies to combat staphylococcal infections.Int J Med Microbiol. 2010 Aug;300(6):402-10. doi: 10.1016/j.ijmm.2010.04.015. Epub 2010 May 23. Int J Med Microbiol. 2010. PMID: 20547101 Review.
-
Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.Vaccine. 2007 Jun 28;25(27):5053-61. doi: 10.1016/j.vaccine.2007.04.067. Epub 2007 May 15. Vaccine. 2007. PMID: 17532546
-
Vaccination and passive immunisation against Staphylococcus aureus.Int J Antimicrob Agents. 2008 Nov;32 Suppl 1:S71-8. doi: 10.1016/j.ijantimicag.2008.06.009. Epub 2008 Aug 30. Int J Antimicrob Agents. 2008. PMID: 18757184 Review.
Cited by
-
An antidote for Staphylococcus aureus pneumonia?J Exp Med. 2008 Feb 18;205(2):271-4. doi: 10.1084/jem.20080167. Epub 2008 Feb 11. J Exp Med. 2008. PMID: 18268043 Free PMC article.
-
Immunotherapy synergizes with debridement and antibiotic therapy in a murine 1-stage exchange model of MRSA implant-associated osteomyelitis.J Orthop Res. 2018 Jun;36(6):1590-1598. doi: 10.1002/jor.23801. Epub 2018 Feb 5. J Orthop Res. 2018. PMID: 29405452 Free PMC article.
-
Exploring Staphylococcus aureus pathways to disease for vaccine development.Semin Immunopathol. 2012 Mar;34(2):317-33. doi: 10.1007/s00281-011-0299-z. Epub 2011 Dec 1. Semin Immunopathol. 2012. PMID: 22130613 Free PMC article. Review.
-
Als3-Th-cell-epitopes plus the novel combined adjuvants of CpG, MDP, and FIA synergistically enhanced the immune response of recombinant TRAP derived from Staphylococcus aureus in mice.Immun Inflamm Dis. 2021 Sep;9(3):971-983. doi: 10.1002/iid3.456. Epub 2021 May 19. Immun Inflamm Dis. 2021. PMID: 34010502 Free PMC article.
-
Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis.Eur Cell Mater. 2020 Jan 31;39:96-107. doi: 10.22203/eCM.v039a06. Eur Cell Mater. 2020. PMID: 32003439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous